Investigational ZORYVE cream 0.05% was formulated for the delicate skin of infants and young children with mild to moderate atopic ...
Nektar Therapeutics develops novel immunomodulatory drugs targeting autoimmune diseases and oncology. Click here to read why ...
Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.
LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, ...
Eczema, a chronic skin condition causing itching and inflammation, affects people of all ages. It manifests in various forms ...
Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo ...
Q3 2025 Earnings Call Transcript November 4, 2025 Corvus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.14. Operator: Good afternoon, everyone. Thank ...
INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...
Also called eczema, this is a common condition that causes itchy, dry, and inflamed skin. It usually begins in childhood but can start at any age. Board-certified dermatologists have expertise in ...
Findings showed 56.5% of patients receiving ruxolitinib cream 1.5% achieved IGA-TS compared with 10.8% of those receiving placebo. The Food and Drug Administration (FDA) has approved Opzelura ® ...
In an update to the guidelines for managing atopic dermatitis in adults, four new treatment recommendations are presented. The focused update was published online in the Journal of the American ...
Managed Healthcare Executive (MHE): What are the key clinical differences between pediatric and adult atopic dermatitis (AD), and how do these differences guide treatment decisions? Song: AD is ...